This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CareFusion And ResMed Announce Distribution Agreement For U.S. Hospital Market

SAN DIEGO, July 25, 2011 /PRNewswire/ -- CareFusion (NYSE: CFN), a leading, global medical technology company and ResMed (NYSE: RMD), a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing and managing sleep-disordered breathing and other respiratory disorders today announced a five-year agreement providing CareFusion the exclusive right to distribute the ResMed Stellar™ 100 and 150 non-invasive ventilators (NIV) and their related accessories into the U.S. institutional healthcare market.

The agreement, effective immediately, provides strategic benefits to both companies. CareFusion will now have a more competitive offering in the institutional NIV market, which is expected to grow by more than 6 percent annually. For ResMed, it provides a timely introduction of its new ventilation products, with their unique performance, size and mobility features valuable to clinicians, caregivers and patients, via CareFusion's long-standing relationships with U.S. hospitals, long-term acute care and skilled nursing facilities. CareFusion will also market and sell the Stellar 100 and 150 related accessories, including tubing and filters.

"The addition of ResMed's Stellar ventilator fills an important need in the respiratory care market segment for our customers," said Tony Lopez, senior vice president and general manager of Respiratory Care at CareFusion. "This strategic agreement also directly aligns with our mission to improve health care costs and quality care to patients."

"Our partnership with CareFusion creates a strong strategic fit and allows ResMed to effectively address the U.S. institutional market with an established leader in the industry," commented Geoff Neilson, ResMed's president, respiratory care strategic business unit. "The Stellar ventilator provides CareFusion with a product having differentiated features and a competitive price point. We have established a good relationship with CareFusion and look forward to it being a long-standing one."  

About the Stellar 100 and 150 non-invasive ventilators

The Stellar ventilators are small, quiet, and versatile and deliver ResMed's high-quality ventilation performance for adult and pediatric patients, with both invasive and non-invasive applications. In addition, it has several monitoring features caregivers will especially appreciate, such as ResMed's leading leak-compensation algorithm, TiControl™ and on-screen waveforms for managing leak and patient-ventilator synchrony — two common problems that occur when administering non-invasive ventilation in an institutional setting. It is also portable with a built-in rechargeable battery. The ResMed Stellar 100 and 150 were cleared by the Food and Drug Administration (FDA) earlier this year.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs